MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 diabetes. The device contains a powdered form of glucagon and can be remotely triggered—either manually or automatically by a glucose monitor—to release the hormone when blood sugar drops too low. This offers a potentially life-saving safety net, especially during sleep or for young children.
Source:
Read full article at www.sciencedaily.com
Medical Disclaimer:
This content is for informational and educational purposes only.
It does not replace professional medical advice.
